Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064)

NCT00831545 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

162

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastases of Central Nervous System
Melanoma
Breast Neoplasm
Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: Temozolomide

Sponsor

Merck Sharp & Dohme LLC

Collaborators

[object Object]